AC Immune SA (ACIU)
NASDAQ: ACIU · IEX Real-Time Price · USD
3.480
-0.150 (-4.13%)
At close: Jul 19, 2024, 4:00 PM
3.500
+0.020 (0.57%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
AC Immune Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for AC Immune stock have an average target of 12, with a low estimate of 8.00 and a high estimate of 16. The average target predicts an increase of 244.83% from the current stock price of 3.48.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 31, 2024.
Analyst Ratings
The average analyst rating for AC Immune stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
BTIG | BTIG | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +129.89% | May 31, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +359.77% | Mar 15, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +359.77% | Nov 13, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +359.77% | Aug 7, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +359.77% | Jun 28, 2023 |
Financial Forecast
Revenue This Year
61.44M
from 14.80M
Increased by 315.09%
Revenue Next Year
120.56M
from 61.44M
Increased by 96.23%
EPS This Year
-0.20
from -0.64
EPS Next Year
-0.10
from -0.20
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 95.6M | 191.1M | 178.8M | 249.8M | 318.9M |
Avg | 61.4M | 120.6M | 67.5M | 81.4M | 110.4M |
Low | n/a | 23.9M | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 545.6% | 211.0% | 48.3% | 269.9% | 291.6% |
Avg | 315.1% | 96.2% | -44.0% | 20.6% | 35.6% |
Low | - | -61.1% | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 0.13 | 0.42 | 0.60 | 1.07 | 1.53 |
Avg | -0.20 | -0.10 | -0.40 | 0.07 | 0.25 |
Low | -0.82 | -0.60 | -0.86 | -0.86 | -0.95 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | 2,066.1% |
Avg | - | - | - | - | 248.4% |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.